India and Liberia signed an agreement in December 2025 to elevate pharmaceutical quality standards and regulatory alignment. The pact enables direct export of high-quality Indian generic medicines, technical capacity building for Liberian health authorities, and stringent quality testing to curb counterfeit drugs.